202 related articles for article (PubMed ID: 3165507)
1. Serum CA 125 levels in patients with endometriosis: changes in CA 125 levels during menstruation.
Masahashi T; Matsuzawa K; Ohsawa M; Narita O; Asai T; Ishihara M
Obstet Gynecol; 1988 Sep; 72(3 Pt 1):328-31. PubMed ID: 3165507
[TBL] [Abstract][Full Text] [Related]
2. Serum CA 125 levels in preoperative evaluation of pelvic masses.
Vasilev SA; Schlaerth JB; Campeau J; Morrow CP
Obstet Gynecol; 1988 May; 71(5):751-6. PubMed ID: 3162763
[TBL] [Abstract][Full Text] [Related]
3. Differences in the blood serum levels of soluble HLA-G concentrations between the menstrual cycle phases and menopause in patients with ovarian endometriosis and uterine leiomyoma.
Basta P; Mach P; Pitynski K; Bednarek W; Klimek M; Zietek J; Zajac K; Wicherek L
Neuro Endocrinol Lett; 2009 Mar; 30(1):91-8. PubMed ID: 19300397
[TBL] [Abstract][Full Text] [Related]
4. Alterations in RCAS1 serum concentration levels during menstrual cycle in patients with uterine leiomyoma and lack of analogical changes in adenomyosis.
Wicherek L
Gynecol Obstet Invest; 2009; 67(3):195-201. PubMed ID: 19122463
[TBL] [Abstract][Full Text] [Related]
5. [Significance of CA 125 antigen levels in patients with ovarian cancer].
Shimizu Y; Fujiwara H; Akagaki E; Hirota K; Kono M; Irie T; Miura S; Okudaira Y
Gan To Kagaku Ryoho; 1986 Jan; 13(1):46-52. PubMed ID: 3455806
[TBL] [Abstract][Full Text] [Related]
6. CA 125 levels measured in different phases of the menstrual cycle in screening for endometriosis.
O'Shaughnessy A; Check JH; Nowroozi K; Lurie D
Obstet Gynecol; 1993 Jan; 81(1):99-103. PubMed ID: 8416469
[TBL] [Abstract][Full Text] [Related]
7. Serum CA 125 antigen levels and disease severity in patients with endometriosis.
Moloney MD; Thornton JG; Cooper EH
Obstet Gynecol; 1989 May; 73(5 Pt 1):767-9. PubMed ID: 2704505
[TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of tumor-associated mucin-type glycoprotein CA 54/61 in ovarian cancers: comparison with CA 125.
Suzuki M; Sekiguchi I; Tamada T
Obstet Gynecol; 1990 Sep; 76(3 Pt 1):422-7. PubMed ID: 2381620
[TBL] [Abstract][Full Text] [Related]
9. [Differential diagnosis between leiomyomata uteri and adenomyosis using CA 125 as a new tumor marker of ovarian carcinoma].
Takahashi K; Kijima S; Yoshino K; Shibukawa T; Moriyama M; Iwanari O; Sawada K; Matsunaga I; Murao F; Kitao M
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Apr; 37(4):591-5. PubMed ID: 3857281
[TBL] [Abstract][Full Text] [Related]
10. CA 125 in peritoneal fluid: reliable values at high dilutions.
Barbati A; Anceschi MM; Di Renzo GC; Cosmi EV
Obstet Gynecol; 1992 Jun; 79(6):1011-5. PubMed ID: 1579297
[TBL] [Abstract][Full Text] [Related]
11. [Studies on clinical usefulness of new tumor markers of ovarian cancer, CA54/61 and CA602--III. Measurement of serum samples from patients with various benign or malignant diseases].
Nozawa S; Udagawa Y; Sasaki H; Ito K; Akiya K; Terashima Y; Takamizawa H; Ohkura H; Fujimoto S; Hashimoto M
Gan To Kagaku Ryoho; 1994 May; 21(6):823-32. PubMed ID: 8185340
[TBL] [Abstract][Full Text] [Related]
12. [Studies on CA 125, CA 19-9, TPA and IAP as tumor markers in patients with ovarian cancer].
Negishi Y; Furuno K; Sano Y; Hirata T; Utsunomiya A; Nakajima H; Okabe K; Shimizu K; Akiya K; Fujiwara Y
Gan No Rinsho; 1985 May; 31(6 Suppl):655-63. PubMed ID: 2993692
[TBL] [Abstract][Full Text] [Related]
13. Serum CA 125 measurements in the diagnosis of endometriosis recurrence.
Fedele L; Arcaini L; Vercellini P; Bianchi S; Candiani GB
Obstet Gynecol; 1988 Jul; 72(1):19-22. PubMed ID: 2967943
[TBL] [Abstract][Full Text] [Related]
14. Serum Ca-125 concentrations in endometriosis.
Fedele L; Arcaini L; Vercellini P; Marchini M; Baglioni A; Bianchi S
Acta Eur Fertil; 1989; 20(3):137-9. PubMed ID: 2533779
[TBL] [Abstract][Full Text] [Related]
15. Alterations in RCAS1 serum concentration levels during the normal menstrual cycle and the lack of analogical changes in ovarian endometriosis.
Wicherek L
Am J Reprod Immunol; 2008 Jun; 59(6):535-44. PubMed ID: 18422812
[TBL] [Abstract][Full Text] [Related]
16. [Clinical evaluation of specificity of serum CA125 as a tumor marker of ovarian carcinoma].
Iwasaka T; Ohkuma Y; Yoshimura T; Sugimori H
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jun; 38(6):917-23. PubMed ID: 2426378
[TBL] [Abstract][Full Text] [Related]
17. Serum CA-125 levels in the diagnosis and management of endometriosis.
Lanzone A; Marana R; Muscatello R; Fulghesu AM; Dell'Acqua S; Caruso A; Mancuso S
J Reprod Med; 1991 Aug; 36(8):603-7. PubMed ID: 1834843
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil to lymphocyte ratio for preoperative diagnosis of uterine sarcomas: a case-matched comparison.
Kim HS; Han KH; Chung HH; Kim JW; Park NH; Song YS; Kang SB
Eur J Surg Oncol; 2010 Jul; 36(7):691-8. PubMed ID: 20570475
[TBL] [Abstract][Full Text] [Related]
19. Measurement of a monoclonal-antibody-defined antigen (90K) in the sera of patients with ovarian cancer.
Scambia G; Panici PB; Baiocchi G; Perrone L; Iacobelli S; Mancuso S
Anticancer Res; 1988; 8(4):761-4. PubMed ID: 3178164
[TBL] [Abstract][Full Text] [Related]
20. Use of CA125 fluctuation during the menstrual cycle as a tool in the clinical diagnosis of endometriosis; a preliminary report.
Kafali H; Artuc H; Demir N
Eur J Obstet Gynecol Reprod Biol; 2004 Sep; 116(1):85-8. PubMed ID: 15294374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
